NEW YORK, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

FedEx Corporation (NYSE: FDX)
Class Period: September 19, 2017 - December 18, 2018
Lead Plaintiff Deadline: August 26, 2019
Join the action: https://www.zlk.com/pslra-1/fedex-corporation-loss-form?wire=3 

Allegations: FedEx Corporation made materially false and/or misleading statements throughout the class period and/or failed to disclose that:  (1) TNT’s overall package volume growth was slowing as TNT’s large customers permanently took their business to competitors after the Cyberattack; (2) as a result of the customer attrition, TNT was experiencing an increased shift in product mix from higher-margin parcel services to lower-margin freight services; (3) the anticipated costs and timeframe to integrate and restore the TNT network were significantly larger and longer than disclosed; (4) FedEx was not on track to achieve TNT synergy targets; and (5) as a result of these undisclosed negative trends and cost issues, FedEx’s positive statements about TNT’s recovery from the Cyberattack, integration into FedEx’s legacy operations, customer mix, customer service levels, profitability, and prospects lacked a reasonable basis.

To learn more about the FedEx Corporation class action contact jlevi@levikorsinsky.com.

Fred's, Inc. (NASDAQGS: FRED)
Class Period: December 20, 2016 - June 28, 2017
Lead Plaintiff Deadline: August 27, 2019
Join the action: https://www.zlk.com/pslra-1/freds-inc-loss-form?wire=3 

According to the filed complaint, defendants made numerous materially false and misleading statements concerning the level of regulatory risk faced by the Original Merger and the Revised Merger which would ultimately cause the termination of the Fred’s Asset Purchase Agreement. Specifically, Defendants made false and/or misleading statements: (i) downplaying or  disputing  contrary  reports  from  journalists  signaling  regulatory  turbulence  in  closing  the merger; (ii) representing that inside knowledge of the FTC gave confidence that the deal would close.

To learn more about the Fred's, Inc. class action contact jlevi@levikorsinsky.com.

Eagle Bancorp, Inc. (NASDAQCM: EGBN)
Class Period: March 2, 2015 - July 17, 2019
Lead Plaintiff Deadline: September 23, 2019
Join the action: https://www.zlk.com/pslra-1/eagle-bancorp-inc-loss-form?wire=3 

Allegations: During the class period, Eagle Bancorp, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Eagle Bancorp’s internal controls and procedures and compliance policies were inadequate; (ii) the foregoing shortcoming created a foreseeable risk of heightened regulatory scrutiny and the need for the Company undertake its own internal investigations; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more about the Eagle Bancorp, Inc. class action contact jlevi@levikorsinsky.com.

Abiomed, Inc. (NASDAQGS: ABMD)
Class Period: January 31, 2019 - July 31, 2019
Lead Plaintiff Deadline: October 7, 2019
Join the action: https://www.zlk.com/pslra-1/abiomed-inc-loss-form?wire=3 

Allegations: Abiomed, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Abiomed’s revenue growth was in decline; (ii) the Company did not have a sufficient plan in place to stem its declining revenue growth; (iii) the Company was unlikely to restore its revenue growth over the next several fiscal quarters; (iv) consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company’s prior projections and market expectations; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

To learn more about the Abiomed, Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com